Alpha-adrenergic treatments in urology;Traitements par alpha-stimulants en urologie

Progres en Urologie

Volumn 10, Issue 3, 2000, Pages 370-378

  Chartier Kastler, Emmanuel ^a   Robain, Gilberte ^b   Amarenco, Gérard ^c   Richard, François ^a   Durand, Alain ^d   Denys, Pierre ^e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL CHARLES FOIX   (France)

^c HÔPITAL ROTHSCHILD   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Alpha receptors; Autonomous nervous system; Incontinence; Pharmacology; Voiding disorders

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

HUMAN; INNERVATION; MICTURITION DISORDER; PHYSIOLOGY; REVIEW; UROGENITAL SYSTEM;

ADRENERGIC ALPHA-AGONISTS; HUMANS; RECEPTORS, ADRENERGIC; URINATION DISORDERS; UROGENITAL SYSTEM;

EID: 0034203889     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Urinary incontinence in adults: acute and chronic management in clinical practice guideline. In:. 2nd Edition ed: U.S. Department of Health and Human Services, 1996.
2. VIDAL, le dictionnaire, Paris: Les éditions du Vidai, 1998.
3. ALM P .: Cholinergic innervation of the human urethra and urinary bladder. Acta Pharmacol Toxicol, 1978,43,56-.
4. ALM P., ZYGMUNT P., ISELIN C., LARSSON B., UVELIUS B., WERNER S., ANDERSON K.: Nitric oxide synthase-immunoreactive, adrenergic, cholinergic and peptidergic nerves of the female rat urinary tract : a comparative study. Auton Nerv. Syst.,1995,5, 105-114.
5. AMARCK P., KINN A., NERGARDH A.: Receptor function studies in specimens from the proximal human urethra obtained by transurethral resection. Urol. Res., 1992, 20, 55-58.
6. ANDEM. Evaluation et état des connaissances concernant l'incontinence urinaire de l'adulte. Traitement pharmacologique. In: Paris, Andem, 1995. pp. 97-108.
7. ANDERSON K., FOVEAUS M., HEDLUND H., HOLMQUIST F., SUNDLER F.: Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human urinary bladder. J. Urol., 1989, 141, 324 A, abstract 619.
8. BEISLAND H.O., FOSSBERG E., MOER A., et al .: Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. Urol. Int., 1984,39,211-216.
9. BERGGREN A., DAHLSTRÖM A., RUBENSON A., SILLEN U.: Involvement of kappa opioid mechanisms in the motor control of the urinary bladder. Neurourol. Urodyn., 1990, 9, 373-374.
10. BERGGREN A., RUBENSON A., SILLEN U.: Involvement of opioid mechanisms in peripheral motor control of detrusor muscle. Pharmacol. Toxicol., 1992, 71, 179-184.
11. BHAT M., MISHRA S., RAVRIPRAKASH V.: Differential susceptibility of cholinergic and non-cholinergic neurogenic responses to calcium channel blockers and low Ca2+ medium in rat urinary bladder. Br. J. Pharmacol., 1989, 96, 837-842.
12. BONNER T.: New subtypes of acetylcholine receptors. Trends Pharmacol. Sci., 1989, 11-15.
13. BUDD H.: Brompheniramine in treatment of retrograde ejaculation. Urology, 1975, 5, 520-522.
14. CHARTIER-KASTLER E., AZOUVI P., YAKOVLEFF A., BUSSEL B., RICHARD F., DENYS P.: Intrathecal catheter with subcutaneous port for clonidine test bolus injection: a new route and type of treatment for detrusor hyperreflexia in spinal cord injured patients. Eur. Urol., 2000, 37, 14-17.
15. COLLETS L., LINDSKOG M.: Phenylpropanolamine in treatment of female stress urinary incontinence. Urology, 1987, 30, 398-403.
16. DENYS P., CHARTIER-KASTLER E., AZOUVI P., REMY-NERIS O., BUSSEL B.: Intrathecal clonidine for refractory detrusor hyperreflexia in spinal cord injured patients: a preliminary report. J. Urol., 1998, 160, 2137-2138.
17. DRAWZ B., DRAWZ G., BERNDT W.: Retrograde ejaculation from an urological point of view and the present status of possible therapies. Z. Urol. Nephrol., 1989, 82, 127-134.
18. EK A., ANDERSSON K., PERSSON C.: Adrenoreceptor and cholinoreceptor mediated responses of the isolated human urethra. Scand. J., Urol Nephrol., 1977, 11, 97-102.
19. EVRON S., SAMUELOFF A., SIMON A., DRENGER B., MAGORA F.: Urinary function during epidural analgesia with methadone and morphine in post-caeseran section patients. Pain, 1985, 23,135.
20. FOSSBERG E., BEISLAND H., LUNDGREN R.: Stress incontinence in females : treatment with phenylpropanolamine. Urol. Int., 1983 ,38, 293-299.
21. GAROFALO F., LALANNE G., NANNI G.: Midodrine for female incontinence: a preliminary report. Clin. Ther., 1986,9, 44-46.
22. GOODMAN and GILMAN'S. The pharmacological basis of therapeutics. Ed. Hardman G., Limbird Lee E. New York, ninth ed., 1996.
23. HALL J., FLOWERS J., MORTON IK.: A pharmacological study of NK1 and NK2 tachykinin receptors characteristics in the rat isolated urinary bladder. Br. J. Pharmacol., 1992, 107, 777-784.
24. HANCOCK A. Adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology. Drug Developt. Res., 1996, 39, 54-107.
25. HOYLE C.: Non adrenergic, non cholinergic control of the urinary bladder. World J. Urol., 1994. 12, 233-244.
26. JONAS D.: Treatment of female stress incontinence with midodrinc: preliminary report. J. Urol., 1977, 118, 980-982.
27. JONAS D., LINZBACH P., WEBER W.: The use of midodrin in the treatment of ejaculation disorders following lymphadenectomy. Eur. Urol., 1979, 5, 184-187.
28. KLARSKOV P., HORBY-PETERSEN J.: Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig. J. Urol., 1984, 131, 1000-1004.
29. KOHN F., SCHILL W.: The alpha sympathomimetic midodrin as a tool of diagnosis ans treatment of sperm transport disturbances. Andrologia, 1994, 26, 283-287.
30. KOYANAGI T.: Further observation on the dcncrvation supersensitivity of the urethra in patients with chronic neurogenic bladders. J. Urol., 1979, 122, 348-351.
31. LEVIN R., WEIN A.: Distribution and function of adrenergic receptors in the urinary bladder of the rabbit. Mol. Pharmacol., 1979, 16,441-448.
32. LOSE G., RIX P., DIERNOES E., ALEXANDER N.: Norfenefrine in the treatment of female stress incontinence. A double-blind controlled trial. Urol. Int., 1988, 43, 11-15.
33. LUDDENS H., WISDEN W.: Function and pharmacology of multiple GABA A receptor subunits. Trends Pharmacol. Sci., 1991, 12, 49-51.
34. MAGGI C., GIULANI S., PATACHINI R., BARBANTI G., TURINI D., MELI A.: Contractile responses of the human urinary bladder, renal pelvis and renal artery to endothelins and sarafotoxin S6b. Br. J. Pharmacol., 1990, 21, 247-249.
35. MATTIASON A.: Management of overactive bladder - looking to the future. Urology, 1997, 50, 111-113.
36. MATTIASSON A., ANDERSSON K., SJÖGGREN C.: Urethral sensitivity to a-adrenoreceptors stimulation and blockade in patients with parasympatically decentralized lower urinary tract and in healthy volunteers. Neurourol. Urodyn. ,1984, 3, 223-233.
37. McTAVISH D., GOA K.: Midodrine A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs, 1989, 38, 757-777.
38. MOLINA L., BEJANY D., LYNNE C., POLITANO V.: Diluted epinephrine solution for the treatment of priapism. J. Urol., 1989, 1127-1128.
39. MOTTET N., COSTA P., BALI J.P.: Système nerveux végétatif et physiologie prostatique. Particularités du systême alpha adrénergique. Prog. Urol., 1999, 9, 26-36.
40. NORDLING J, MEYHOFF H, CHRISTENSEN N.: Effect of clonidine (Catapressan) on urethral pressure. Invest. Urol.,1979, 16, 289-291.
41. NORDLING J., MEYHOFF H., CHRISTENSEN N.: Influence of sympathetic tonus and plasma noradrenaline on urethral pressure. Scand. J. Urol. Nephrol., 1981, 15, 1-6.
42. RAZ S., KAUFMAN J., ELLISON G., MAYERS L.: Methyldopa in treatment of neurogenic bladder disorders. Urology, 1977, 9, 188-190.
43. RILEY A., RILEY A.: Partial ejaculatory incompetence : the therapeutic effect of midodrine . an orally selective adrenoreceptor agonist. Eur. Urol., 1982, 8, 155-160.
44. SERRATE R., PRATS J., RÉGUE R., RUIS G.: The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections. Int. Urol. Nephrol., 1992, 24, 389-392.
45. STEWART B., BERGANT J.: Correction of retrograde ejaculation by sympathomimetic medication : preliminary report. Fertil. Steril., 1974, 25, 1073-1074.
46. TANIGUCHI N., HAMADA K., OGASAWARA T., UKAI Y., YOSHIKUNI Y., KIMURA K.: NS-49: an alA-adrenoreceptor. selectively increases intraurethral pressure in dogs. Eur. J. Pharmacol., 1996, 318, 117-122.
47. VAN DRIEL M., JOOSTEN E., MENSINK H.: Intracorporeal self injection with epinephrine as treatment for idiopathic recurrent priapism. Eur. Urol., 1990, 17, 95-96.
48. VIRAG R., BACHIR D., LEE K., GALACTEROS F.: Preventive treatment of priapism in sickle cell disease with oral and self-administred intraeavernous injection of etilephrine. Urology. 1996, 47, 777-781.
49. WEIL E., EERDMANS P., DIJKMAN G., TAMUSSINO K., FEYEREISL J., VIERHOUT M., SCHMIDBAUER C., EGARTER C., KOLLE D., PLASMAN J., HEIDLER H., ABBUHL B., WEIN W.: Randomized double-blind placebo-controlled multicentcr evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. Int. Urogynecol. J. Pelvic Floor Dysfunct, 1998, 9, 145-150.